2021级博士研究生-熊媛

发布者:交叉科学研究院-01发布时间:2023-03-20浏览次数:47

个人简历

2014.9-2018.6   石河子大学           中药学专业,获学士学位

2018.9-2021.6   石河子大学&上海中医药大学  药学专业,获硕士学位(导师:唐辉、葛广波)

2021.9-至今    上海中医药大学              中药学专业,在读博士研究生(导师:葛广波)

所获荣誉

2022年    上海市研究生学术论坛优秀论文一等奖

代表性文章

1. Xiong Y#, Zhu GH#, Ge GB*, et al. Flavonols in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: inhibition potentials, covalent binding sites and inhibitory mechanisms. International Journal of Biological Macromolecules. 2021; 187:976-987. (Q1, IF = 8.025)

2. Xiong Y#, Zhu GH#, Ge GB*, et al. Discovery of naturally occurring inhibitors against SARS-CoV-2 3CLpro from Ginkgo biloba leaves via large-scale screening. Fitoterapia. 2021;04,16. (Q3, IF = 3.204)

3. Zhang JW#, Xiong Y#, Ge GB*, et al. Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CLpro inhibitors for treating COVID-19. European Journal of Medicinal Chemistry. 2022; 228: 114030. (Q1, IF = 8.039)

4. Hu Q#, Xiong Y#, Ge GB*, et al. The SARS-CoV-2 main protease (Mpro): Structure, function, and emerging therapies for COVID-19. MedComm, 2022 Jul 14;3(3): e151.

5. Zhao YT#, Xiong Y#, Ge GB*, et al. Synthesis and structure-activity relationship of 3-arylisoquinolone analogues as novel highly specific hCES2A inhibitors. ChemMedchem. 16(2); 388-398. (Q4, IF = 3.540)